COVID-19 vaccine (Liaoning Chengda/Tsinghua University)

N/A

Report date: 2025/01/26 19:30:11

Base Information

Drug NameCOVID-19 vaccine (Liaoning Chengda/Tsinghua University)
Drug Alias NameCOVID-19 polypeptide vaccine (Liaoning Chengda/Tsinghua University)protein subunit vaccine(Liaoning Chengda/Tsinghua University)protein subunit vaccine(Liaoning Chengda/Tsinghua University)SARS-CoV-2 vaccine (Liaoning Chengda/Tsinghua University)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTsinghua University
China Registration ClassN/A

Develop Information

Active CompaniesLiaoning Chengda Co LtdTsinghua University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A